Activation of this pathway directly upregulates the expression of the immunosuppressive molecules PD-L1 and CD47, conferring an immune escape advantage to tumor cells and facilitating tumor growth and metastatic dissemination[197]. The gene discussed is CD274; the disease is neoplasm.